These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [The clinical application value of brain 18F-FDG PET/CT in the diagnostics of Parkinsonian syndromes]. Gu Q, Chen SF, Chen KL, Huang YY, Ge JJ, Zuo CT, Cui M, Dong Q, Yu JT. Zhonghua Yi Xue Za Zhi; 2023 Nov 07; 103(41):3294-3300. PubMed ID: 37926574 [Abstract] [Full Text] [Related]
5. Voxel based comparison of glucose metabolism in the differential diagnosis of the multiple system atrophy using statistical parametric mapping. Juh R, Pae CU, Lee CU, Yang D, Chung Y, Suh T, Choe B. Neurosci Res; 2005 Jul 07; 52(3):211-9. PubMed ID: 15927722 [Abstract] [Full Text] [Related]
6. The utility of FDG-PET in the differential diagnosis of Parkinsonism. Brajkovic L, Kostic V, Sobic-Saranovic D, Stefanova E, Jecmenica-Lukic M, Jesic A, Stojiljkovic M, Odalovic S, Gallivanone F, Castiglioni I, Radovic B, Trajkovic G, Artiko V. Neurol Res; 2017 Aug 07; 39(8):675-684. PubMed ID: 28378615 [Abstract] [Full Text] [Related]
7. The value of putaminal diffusion imaging versus 18-fluorodeoxyglucose positron emission tomography for the differential diagnosis of the Parkinson variant of multiple system atrophy. Baudrexel S, Seifried C, Penndorf B, Klein JC, Middendorp M, Steinmetz H, Grünwald F, Hilker R. Mov Disord; 2014 Mar 07; 29(3):380-7. PubMed ID: 24243813 [Abstract] [Full Text] [Related]
8. Clinical features, MRI, and 18F-FDG-PET in differential diagnosis of Parkinson disease from multiple system atrophy. Zhao P, Zhang B, Gao S, Li X. Brain Behav; 2020 Nov 07; 10(11):e01827. PubMed ID: 32940411 [Abstract] [Full Text] [Related]
10. Comparison of univariate and multivariate analyses for brain [18F]FDG PET data in α-synucleinopathies. Carli G, Meles SK, Reesink FE, de Jong BM, Pilotto A, Padovani A, Galbiati A, Ferini-Strambi L, Leenders KL, Perani D. Neuroimage Clin; 2023 Nov 07; 39():103475. PubMed ID: 37494757 [Abstract] [Full Text] [Related]
12. Differentiating multiple system atrophy from Parkinson's disease: contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging. Ghaemi M, Hilker R, Rudolf J, Sobesky J, Heiss WD. J Neurol Neurosurg Psychiatry; 2002 Nov 07; 73(5):517-23. PubMed ID: 12397143 [Abstract] [Full Text] [Related]
14. The putaminal abnormalities on 3.0T magnetic resonance imaging: can they separate parkinsonism-predominant multiple system atrophy from Parkinson's disease? Feng JY, Huang B, Yang WQ, Zhang YH, Wang LM, Wang LJ, Zhong XL. Acta Radiol; 2015 Mar 07; 56(3):322-8. PubMed ID: 24619850 [Abstract] [Full Text] [Related]
15. Transcranial sonography and [18F]fluorodeoxyglucose positron emission tomography for the differential diagnosis of parkinsonism: a head-to-head comparison. Hellwig S, Reinhard M, Amtage F, Guschlbauer B, Buchert R, Tüscher O, Weiller C, Niesen WD, Meyer PT. Eur J Neurol; 2014 Jun 07; 21(6):860-6. PubMed ID: 24602186 [Abstract] [Full Text] [Related]
16. Differentiating between multiple system atrophy and Parkinson's disease by positron emission tomography with 18F-dopa and 18F-FDG. Otsuka M, Kuwabara Y, Ichiya Y, Hosokawa S, Sasaki M, Yoshida T, Fukumura T, Kato M, Masuda K. Ann Nucl Med; 1997 Aug 07; 11(3):251-7. PubMed ID: 9310175 [Abstract] [Full Text] [Related]
20. Comparison of diffusion-weighted imaging and [123I]IBZM-SPECT for the differentiation of patients with the Parkinson variant of multiple system atrophy from those with Parkinson's disease. Seppi K, Schocke MF, Donnemiller E, Esterhammer R, Kremser C, Scherfler C, Diem A, Jaschke W, Wenning GK, Poewe W. Mov Disord; 2004 Dec 07; 19(12):1438-45. PubMed ID: 15390073 [Abstract] [Full Text] [Related] Page: [Next] [New Search]